Page last updated: 2024-09-05

tesaglitazar and Elevated Cholesterol

tesaglitazar has been researched along with Elevated Cholesterol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boesten, LS; Camejo, G; Emeis, JJ; Havekes, LM; Jukema, JW; Kooistra, T; Lundholm, E; van Vlijmen, BJ; Zadelaar, AS	1

Other Studies

1 other study(ies) available for tesaglitazar and Elevated Cholesterol

Article	Year
Dual PPARalpha/gamma agonist tesaglitazar reduces atherosclerosis in insulin-resistant and hypercholesterolemic ApoE3Leiden mice. Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:11* Topics: Alkanesulfonates; Animals; Apolipoprotein E3; Apolipoproteins E; Atherosclerosis; Biomarkers; Blood Vessels; Cell Adhesion; Cholesterol; Cholesterol, Dietary; Collagen; Dietary Fats; Female; Hypercholesterolemia; Inflammation; Insulin Resistance; Lipids; Lipoproteins; Macrophages; Mice; Mice, Transgenic; Monocytes; NF-kappa B; Phenylpropionates; PPAR alpha; PPAR gamma	2006

Article

Year

Dual PPARalpha/gamma agonist tesaglitazar reduces atherosclerosis in insulin-resistant and hypercholesterolemic ApoE*3Leiden mice.

Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:11

Topics: Alkanesulfonates; Animals; Apolipoprotein E3; Apolipoproteins E; Atherosclerosis; Biomarkers; Blood Vessels; Cell Adhesion; Cholesterol; Cholesterol, Dietary; Collagen; Dietary Fats; Female; Hypercholesterolemia; Inflammation; Insulin Resistance; Lipids; Lipoproteins; Macrophages; Mice; Mice, Transgenic; Monocytes; NF-kappa B; Phenylpropionates; PPAR alpha; PPAR gamma

2006